Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs

Journal of Hepatology

Volumn 62, Issue S1, 2015, Pages S76-S86

  Locarnini, Stephen ^a   Hatzakis, Angelos ^b   Chen, Ding Shinn ^c   Lok, Anna ^d  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Acute hepatitis B; Chronic hepatitis B; Chronic liver disease; Epidemiology; Hepatitis B vaccine; Hepatocellular carcinoma; Prevention; Public policy; Treatment; WHO

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; INTERFERON; NUCLEOSIDE ANALOG; HEPATITIS B(E) ANTIGEN;

ANTIVIRAL THERAPY; CHRONIC HEPATITIS B; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE POLICY; HEPATITIS B; HUMAN; INCIDENCE; INFECTION CONTROL; LIVER CELL CARCINOMA; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; VACCINATION; WORLD HEALTH ORGANIZATION; BLOOD; IMMUNOLOGY; POLICY;

HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; INTERFERONS; PUBLIC POLICY; VACCINATION;

EID: 84934335209     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.01.018     Document Type: Review

References (91)

1. B.S. Blumberg, H.J. Alter, and S. Visnich A "New" antigen in leukemia sera JAMA 191 1965 541 546 Epub 1965/02/15
2. A. Kay, and F. Zoulim Hepatitis B virus genetic variability and evolution Virus Res 127 2007 164 176 Epub 2007/03/27
3. F. Kurbanov, Y. Tanaka, and M. Mizokami Geographical and genetic diversity of the human hepatitis B virus Hepatol Res 40 2010 14 30 Epub 2010/02/17
4. S. Locarnini, M. Littlejohn, M.N. Aziz, and L. Yuen Possible origins and evolution of the hepatitis B virus (HBV) Semin Cancer Biol 23 2013 561 575 Epub 2013/09/10
5. S. Schaefer Hepatitis B virus taxonomy and hepatitis B virus genotypes World J Gastroenterol 13 2007 14 21 Epub 2007/01/09
6. G. Fattovich, F. Bortolotti, and F. Donato Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors J Hepatol 48 2008 335 352 Epub 2007/12/22
7. S.J. Hadziyannis Natural history of chronic hepatitis B in Euro-Mediterranean and African countries J Hepatol 55 2011 183 191 Epub 2011/01/18
8. B.J. McMahon Natural history of chronic hepatitis B Clin Liver Dis 14 2010 381 396 Epub 2010/07/20
9. G.V. Papatheodoridis, E. Manesis, and S.J. Hadziyannis The long-term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B J Hepatol 34 2001 306 313 Epub 2001/04/03
10. A. Kramvis, M. Kew, and G. Francois Hepatitis B virus genotypes Vaccine 23 2005 2409 2423 Epub 2005/03/09
11. Y. Tanaka, I. Hasegawa, T. Kato, E. Orito, N. Hirashima, S.K. Acharya, and et al. A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D Hepatology 40 2004 747 755 Epub 2004/09/07
12. C.J. Chen, H.I. Yang, J. Su, C.L. Jen, S.L. You, S.N. Lu, and et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level JAMA 295 2006 65 73 Epub 2006/01/05
13. J.D. Chen, H.I. Yang, U.H. Iloeje, S.L. You, S.N. Lu, L.Y. Wang, and et al. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death Gastroenterology 138 2010 1747 1754 Epub 2010/02/02
14. H.I. Yang, S.N. Lu, Y.F. Liaw, S.L. You, C.A. Sun, L.Y. Wang, and et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma N Engl J Med 347 2002 168 174 Epub 2002/07/19
15. H.B. El-Serag Epidemiology of viral hepatitis and hepatocellular carcinoma Gastroenterology 142 2012 1264 1273 e1. Epub 2012/04/28
16. J.J. Ott, G.A. Stevens, J. Groeger, and S.T. Wiersma Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity Vaccine 30 2012 2212 2219 Epub 2012/01/26
17. R.S. Tedder, A.J. Rodger, L. Fries, S. Ijaz, M. Thursz, W. Rosenberg, and et al. The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up call Clin Infect Dis 56 2013 951 960 Epub 2012/12/12
18. J.J. Chu, T. Wormann, J. Popp, G. Patzelt, M.K. Akmatov, A. Kramer, and et al. Changing epidemiology of hepatitis B and migration-a comparison of six Northern and North-Western European countries Eur J Public Health 23 2013 642 647 Epub 2012/11/08
19. R. Lozano, M. Naghavi, K. Foreman, S. Lim, K. Shibuya, V. Aboyans, and et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2095 2128 Epub 2012/12/19
20. J.H. Kao, and D.S. Chen Global control of hepatitis B virus infection Lancet Infect Dis 2 2002 395 403 Epub 2002/07/20
21. D.S. Chen Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B J Hepatol 50 2009 805 816 Epub 2009/02/24
22. P. Maupas, J.P. Chiron, F. Barin, P. Coursaget, A. Goudeau, J. Perrin, and et al. Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal) Lancet 1 1981 289 292 Epub 1981/02/07
23. W. Szmuness, C.E. Stevens, E.J. Harley, E.A. Zang, W.R. Oleszko, D.C. William, and et al. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States N Engl J Med 303 1980 833 841 Epub 1980/10/09
24. P. Valenzuela, A. Medina, W.J. Rutter, G. Ammerer, and B.D. Hall Synthesis and assembly of hepatitis B virus surface antigen particles in yeast Nature 298 1982 347 350 Epub 1982/07/22
25. M.J. Alter, S.C. Hadler, H.S. Margolis, W.J. Alexander, P.Y. Hu, F.N. Judson, and et al. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies JAMA 263 1990 1218 1222 Epub 1990/03/02
26. J.A. Arevalo, and A.E. Washington Cost-effectiveness of prenatal screening and immunization for hepatitis B virus JAMA 259 1988 365 369 Epub 1988/01/15
27. D.S. Chen, N.H. Hsu, J.L. Sung, T.C. Hsu, S.T. Hsu, Y.T. Kuo, and et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers JAMA 257 1987 2597 2603 Epub 1987/05/15
28. P. Van Damme, M. Kane, and A. Meheus Integration of hepatitis B vaccination into national immunisation programmes. Viral Hepatitis Prevention Board BMJ 314 1997 1033 1036 Epub 1997/04/05
29. Hepatitis B vaccine in the expanded programme of immunisation: the Gambian experience. The Gambia Hepatitis Study Group Lancet 1 1989 1057 1059 Epub 1989/05/13
30. T.A. Ruff, D.M. Gertig, B.F. Otto, I.D. Gust, A. Sutanto, T.I. Soewarso, and et al. Lombok Hepatitis B Model Immunization Project: toward universal infant hepatitis B immunization in Indonesia J Infect Dis 171 1995 290 296 Epub 1995/02/01
31. D.S. Chen Hepatitis B virus infection, its sequelae and prevention in Taiwan 1987 Springer-Verlag Tokyo
32. D.S. Chen Fighting against viral hepatitis: lessons from Taiwan Hepatology 54 2011 381 392 Epub 2011/07/02
33. Y.H. Ni, M.H. Chang, J.F. Wu, H.Y. Hsu, H.L. Chen, and D.S. Chen Minimization of hepatitis B infection by a 25-year universal vaccination program J Hepatol 57 2012 730 735 Epub 2012/06/07
34. J.H. Kao, H.M. Hsu, W.Y. Shau, M.H. Chang, and D.S. Chen Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan J Pediatr 139 2001 349 352 Epub 2001/09/20
35. H.L. Chen, C.J. Chang, M.S. Kong, F.C. Huang, H.C. Lee, C.C. Lin, and et al. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination Hepatology 39 2004 58 63 Epub 2004/01/31
36. C.J. Chiang, Y.W. Yang, S.L. You, M.S. Lai, and C.J. Chen Thirty-year outcomes of the national hepatitis B immunization program in Taiwan JAMA 310 2013 974 976 Epub 2013/09/05
37. W.J. Su, C.C. Liu, D.P. Liu, S.F. Chen, J.J. Huang, T.C. Chan, and et al. Effect of age on the incidence of acute hepatitis B after 25 years of a universal newborn hepatitis B immunization program in Taiwan J Infect Dis 205 2012 757 762 Epub 2012/01/21
38. A. Mele, M.E. Tosti, A. Mariano, R. Pizzuti, A. Ferro, B. Borrini, and et al. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges Clin Infect Dis 46 2008 868 875 Epub 2008/02/14
39. R. Bhimma, H.M. Coovadia, M. Adhikari, and C.A. Connolly The impact of the hepatitis B virus vaccine on the incidence of hepatitis B virus-associated membranous nephropathy Arch Pediatr Adolesc Med 157 2003 1025 1030 Epub 2003/10/15
40. H. Xu, L. Sun, L.J. Zhou, L.J. Fang, F.Y. Sheng, and Y.Q. Guo The effect of hepatitis B vaccination on the incidence of childhood HBV-associated nephritis Pediatr Nephrol 18 2003 1216 1219 Epub 2003/10/31
41. M.T. Liao, M.H. Chang, F.G. Lin, I.J. Tsai, Y.W. Chang, and Y.K. Tsau Universal hepatitis B vaccination reduces childhood hepatitis B virus-associated membranous nephropathy Pediatrics 128 2011 e600 e604 Epub 2011/08/24
42. M.H. Chang, D.S. Chen, H.C. Hsu, H.Y. Hsu, and C.Y. Lee Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma Cancer 64 1989 2377 2380 Epub 1989/12/01
43. M.H. Chang, C.J. Chen, M.S. Lai, H.M. Hsu, T.C. Wu, M.S. Kong, and et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group N Engl J Med 336 1997 1855 1859 Epub 1997/06/26
44. C.L. Lee, K.S. Hsieh, and Y.C. Ko Trends in the incidence of hepatocellular carcinoma in boys and girls in Taiwan after large-scale hepatitis B vaccination Cancer Epidemiol Biomarkers Prev 12 2003 57 59 Epub 2003/01/24
45. M.H. Chang, S.L. You, C.J. Chen, C.J. Liu, C.M. Lee, S.M. Lin, and et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study J Natl Cancer Inst 101 2009 1348 1355 Epub 2009/09/18
46. R.C. Li, J.Y. Yang, J. Gong, Y.P. Li, Z.N. Huang, K.X. Fang, and et al. Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma Zhonghua Liu Xing Bing Xue Za Zhi 25 2004 385 387 Epub 2004/07/03
47. K. Wichajarn, P. Kosalaraksa, and S. Wiangnon Incidence of hepatocellular carcinoma in children in Khon Kaen before and after national hepatitis B vaccine program Asian Pac J Cancer Prev 9 2008 507 509 Epub 2008/11/08
48. J. Gwack, S.K. Park, E.H. Lee, B. Park, Y. Choi, and K.Y. Yoo Hepatitis B vaccination and liver cancer mortality reduction in Korean children and adolescents Asian Pac J Cancer Prev 12 2011 2205 2208 Epub 2012/02/03
49. H. Tajiri, H. Tanaka, S. Brooks, and T. Takano Reduction of hepatocellular carcinoma in childhood after introduction of selective vaccination against hepatitis B virus for infants born to HBV carrier mothers Cancer Causes Control 22 2011 523 527 Epub 2010/12/31
50. B.J. McMahon, L.R. Bulkow, R.J. Singleton, J. Williams, M. Snowball, C. Homan, and et al. Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program Hepatology 54 2011 801 807 Epub 2011/05/28
51. Z. Sun, T. Chen, S.S. Thorgeirsson, Q. Zhan, J. Chen, J.H. Park, and et al. Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China Carcinogenesis 34 2013 1800 1805 Epub 2013/01/17
52. E. Bah, M.P. Carrieri, P. Hainaut, Y. Bah, O. Nyan, and M. Taal 20-years of population-based cancer registration in hepatitis B and liver cancer prevention in the Gambia, West Africa PLoS One 8 2013 e75775 Epub 2013/10/08
53. H.L. Chen, L.H. Lin, F.C. Hu, J.T. Lee, W.T. Lin, Y.J. Yang, and et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV Gastroenterology 142 2012 773 781 e2. Epub 2011/12/27
54. W.H. Wen, M.H. Chang, L.L. Zhao, Y.H. Ni, H.Y. Hsu, J.F. Wu, and et al. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention J Hepatol 59 2013 24 30 Epub 2013/03/15
55. W. Chotiyaputta, and A.S. Lok Role of antiviral therapy in the prevention of perinatal transmission of hepatitis B virus infection J Viral Hepat 16 2009 91 93 Epub 2009/01/30
56. A.J. Greenup, P.K. Tan, V. Nguyen, A. Glass, S. Davison, U. Chatterjee, and et al. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus J Hepatol 61 2014 502 507 Epub 2014/05/08
57. G.R. Han, M.K. Cao, W. Zhao, H.X. Jiang, C.M. Wang, S.F. Bai, and et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection J Hepatol 55 2011 1215 1221 Epub 2011/06/28
58. W.M. Xu, Y.T. Cui, L. Wang, H. Yang, Z.Q. Liang, X.M. Li, and et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study J Viral Hepat 16 2009 94 103 Epub 2009/01/30
59. EASL clinical practice guidelines: management of chronic hepatitis B virus infection J Hepatol 57 2012 167 185 Epub 2012/03/23
60. Y.F. Liaw, J.H. Kao, T. Piratvisuth, H. Chan, R.-N. Chien, C.-J. Liu, and et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update Hepatol Int 6 2012 531 561
61. D.S. Chen Long-term protection of hepatitis B vaccine: lessons from Alaskan experience after 15 years Ann Intern Med 142 2005 384 385 Epub 2005/03/02
62. Y. Tamada, H. Yatsuhashi, N. Masaki, M. Nakamuta, E. Mita, T. Komatsu, and et al. Hepatitis B virus strains of subgenotype A2 with an identical sequence spreading rapidly from the capital region to all over Japan in patients with acute hepatitis B Gut 61 2012 765 773 Epub 2011/11/10
63. J.H. Kao, and D.S. Chen Universal hepatitis B vaccination: killing 2 birds with 1 stone Am J Med 121 2008 1029 1031 Epub 2008/11/26
64. J. Fung, S.C. Chan, C. Cheung, M.F. Yuen, K.S. Chok, W. Sharr, and et al. Oral nucleoside/nucleotide analogs without hepatitis B immune globulin after liver transplantation for hepatitis B Am J Gastroenterol 108 2013 942 948 Epub 2013/05/01
65. A.S. Lok, and B.J. McMahon Chronic hepatitis B: update 2009 Hepatology 50 2009 661 662 Epub 2009/08/29
66. U.H. Iloeje, H.I. Yang, and C.J. Chen Natural history of chronic hepatitis B: what exactly has REVEAL revealed? Liver Int 32 2012 1333 1341 Epub 2012/04/19
67. S. Yapali, N. Talaat, and A.S. Lok Management of hepatitis B: our practice and how it relates to the guidelines Clin Gastroenterol Hepatol 12 2014 16 26 Epub 2013/05/11
68. M.A. Konerman, and A.S. Lok Is it more cost effective for patients with chronic hepatitis B to have a trial of interferon before considering nucleos(t)ide analogue therapy? Clin Gastroenterol Hepatol 13 2015 377 385 Epub 2014/08/28
69. G. Sarri, M. Westby, S. Bermingham, G. Hill-Cawthorne, and H. Thomas Diagnosis and management of chronic hepatitis B in children, young people, and adults: summary of NICE guidance BMJ 346 2013 f3893 Epub 2013/06/28
70. P. Marcellin, E. Gane, M. Buti, N. Afdhal, W. Sievert, I.M. Jacobson, and et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study Lancet 381 2013 468 475 Epub 2012/12/14
71. Y.F. Liaw, J.J. Sung, W.C. Chow, G. Farrell, C.Z. Lee, H. Yuen, and et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease N Engl J Med 351 2004 1521 1531 Epub 2004/10/08
72. J.Y. Cho, Y.H. Paik, W. Sohn, H.C. Cho, G.Y. Gwak, M.S. Choi, and et al. Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease Gut 2014
73. W.J. Jeng, I.S. Sheen, Y.C. Chen, C.W. Hsu, R.N. Chien, C.M. Chu, and et al. Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients Hepatology 58 2013 1888 1896 Epub 2013/06/08
74. S.J. Hadziyannis, V. Sevastianos, I. Rapti, D. Vassilopoulos, and E. Hadziyannis Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir Gastroenterology 143 2012 629 636 e1. Epub 2012/06/05
75. S.P. Fletcher, and W.E. Delaney New therapeutic targets and drugs for the treatment of chronic hepatitis B Semin Liver Dis 33 2013 130 137 Epub 2013/06/12
76. H. Yan, B. Peng, Y. Liu, G. Xu, W. He, B. Ren, and et al. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide J Virol 88 2014 3273 3284 Epub 2014/01/07
77. C. Boni, D. Laccabue, P. Lampertico, T. Giuberti, M. Vigano, S. Schivazappa, and et al. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues Gastroenterology 143 2012 963 973 e9. Epub 2012/07/17
78. D.S. Chen, S. Locarnini, S. Wait, S.H. Bae, P.J. Chen, J.Y. Fung, and et al. Report from a Viral Hepatitis Policy Forum on implementing the WHO Framework for Global Action on viral hepatitis in North Asia J Hepatol 59 2013 1073 1080 Epub 2013/07/16
79. B.C. Cowie, K.S. Carville, and J.H. MacLachlan Mortality due to viral hepatitis in the Global Burden of Disease Study 2010: new evidence of an urgent global public health priority demanding action Antivir Ther 18 2013 953 954 Epub 2013/06/13
80. H.J. Alter, P.V. Holland, R.H. Purcell, J.J. Lander, S.M. Feinstone, A.G. Morrow, and et al. Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors Ann Intern Med 77 1972 691 699 Epub 1972/11/01
81. World Hepatitis Alliance Viral Hepatitis: Global Policy; 2010.
82. World Health Assembly. Viral Hepatitis Resolution WHA63.18; 2010.
83. A. Hatzakis, S. Wait, J. Bruix, M. Buti, M. Carballo, M. Cavaleri, and et al. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference J Viral Hepat 18 2011 1 16 Epub 2011/09/22
84. World Health Organisation. Prevention and Control of Viral Hepatitis Infection: Framework for Global Action; 2012.
85. A. Hatzakis, P. Van Damme, K. Alcorn, C. Gore, M. Benazzouz, S. Berkane, and et al. The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference J Viral Hepat 20 2013 1 20 Epub 2013/07/17
86. World Health Assembly. Viral Hepatitis Resolution WHA676; 2014.
87. Y. Dan, J. Wong, S. Hamid, K. Han, J. Jia, C. Liu, and et al. Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countries Hepatol Int 2015 in press
88. V. Arama, H. Leblebicioglu, K. Simon, J.P. Zarski, C. Niederau, F. Habersetzer, and et al. Chronic hepatitis B monitoring and treatment patterns in five European countries with different access and reimbursement policies Antivir Ther 19 2014 245 257 Epub 2013/12/18
89. S.G. Lim, M.O. Aung, S.W. Chung, C.S. Soon, B.H. Mak, and K.H. Lee Patient preferences for hepatitis B therapy Antivir Ther 18 2013 663 670 Epub 2012/12/13
90. F. Zoulim, and S. Locarnini Hepatitis B virus resistance to nucleos(t)ide analogues Gastroenterology 137 2009 1593 1608 e1-2. Epub 2009/09/10
91. World Hepatitis Alliance. Viral Hepatitis: Global Policy; 2013.